While it is established that the PI3K/Akt/mTOR and Wnt/β-catenin pathways are implicated in leukemogenesis, the effects of concurrently inhibiting both signaling pathways have not been explored in T-ALL. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.